{"pmid":32147731,"title":"Diagnosis and Management of First Case of COVID-19 in Canada: Lessons applied from SARS.","text":["Diagnosis and Management of First Case of COVID-19 in Canada: Lessons applied from SARS.","We report diagnosis and management of the first laboratory-confirmed case of coronavirus disease 2019 (COVID-19) hospitalized in Toronto, Canada. No healthcare-associated transmission occurred. In the face of a potential pandemic of COVID-19, we suggest sustainable and scalable control measures developed based on lessons learned from SARS.","Clin Infect Dis","Marchand-Senecal, Xavier","Kozak, Rob","Mubareka, Samira","Salt, Natasha","Gubbay, Jonathan B","Eshaghi, Alireza","Allen, Vanessa","Li, Yan","Bastien, Natalie","Gilmour, Matthew","Ozaldin, Omar","Leis, Jerome A","32147731"],"abstract":["We report diagnosis and management of the first laboratory-confirmed case of coronavirus disease 2019 (COVID-19) hospitalized in Toronto, Canada. No healthcare-associated transmission occurred. In the face of a potential pandemic of COVID-19, we suggest sustainable and scalable control measures developed based on lessons learned from SARS."],"journal":"Clin Infect Dis","authors":["Marchand-Senecal, Xavier","Kozak, Rob","Mubareka, Samira","Salt, Natasha","Gubbay, Jonathan B","Eshaghi, Alireza","Allen, Vanessa","Li, Yan","Bastien, Natalie","Gilmour, Matthew","Ozaldin, Omar","Leis, Jerome A"],"date":"2020-03-10T11:00:00Z","year":2020,"_id":"32147731","week":"202011|Mar 09 - Mar 15","doi":"10.1093/cid/ciaa227","keywords":["(5 max): COVID-19","2019-nCoV","Coronavirus","Infection Prevention","SARS-CoV-2"],"source":"PubMed","locations":["Toronto","Canada"],"countries":["Canada"],"countries_codes":["CAN|Canada"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1661359647814057985,"score":6.7365713,"similar":[{"pmid":32052373,"title":"Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients.","text":["Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients.","A global health emergency has been declared by the World Health Organization as the 2019-nCoV outbreak spreads across the world, with confirmed patients in Canada. Patients infected with 2019-nCoV are at risk for developing respiratory failure and requiring admission to critical care units. While providing optimal treatment for these patients, careful execution of infection control measures is necessary to prevent nosocomial transmission to other patients and to healthcare workers providing care. Although the exact mechanisms of transmission are currently unclear, human-to-human transmission can occur, and the risk of airborne spread during aerosol-generating medical procedures remains a concern in specific circumstances. This paper summarizes important considerations regarding patient screening, environmental controls, personal protective equipment, resuscitation measures (including intubation), and critical care unit operations planning as we prepare for the possibility of new imported cases or local outbreaks of 2019-nCoV. Although understanding of the 2019-nCoV virus is evolving, lessons learned from prior infectious disease challenges such as Severe Acute Respiratory Syndrome will hopefully improve our state of readiness regardless of the number of cases we eventually manage in Canada.","Can J Anaesth","Wax, Randy S","Christian, Michael D","32052373"],"abstract":["A global health emergency has been declared by the World Health Organization as the 2019-nCoV outbreak spreads across the world, with confirmed patients in Canada. Patients infected with 2019-nCoV are at risk for developing respiratory failure and requiring admission to critical care units. While providing optimal treatment for these patients, careful execution of infection control measures is necessary to prevent nosocomial transmission to other patients and to healthcare workers providing care. Although the exact mechanisms of transmission are currently unclear, human-to-human transmission can occur, and the risk of airborne spread during aerosol-generating medical procedures remains a concern in specific circumstances. This paper summarizes important considerations regarding patient screening, environmental controls, personal protective equipment, resuscitation measures (including intubation), and critical care unit operations planning as we prepare for the possibility of new imported cases or local outbreaks of 2019-nCoV. Although understanding of the 2019-nCoV virus is evolving, lessons learned from prior infectious disease challenges such as Severe Acute Respiratory Syndrome will hopefully improve our state of readiness regardless of the number of cases we eventually manage in Canada."],"journal":"Can J Anaesth","authors":["Wax, Randy S","Christian, Michael D"],"date":"2020-02-14T11:00:00Z","year":2020,"_id":"32052373","week":"20207|Feb 10 - Feb 16","doi":"10.1007/s12630-020-01591-x","keywords":["COVID-19"],"source":"PubMed","locations":["Canada"],"countries":["Canada"],"countries_codes":["CAN|Canada"],"topics":["Treatment"],"weight":1,"_version_":1661359647254118403,"score":104.25679},{"pmid":32143990,"title":"The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.","text":["The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.","The 2019-nCoV is officially called SARS-CoV-2 and the disease is named COVID-19. This viral epidemic in China has led to the deaths of over 1800 people, mostly elderly or those with an underlying chronic disease or immunosuppressed state. This is the third serious Coronavirus outbreak in less than 20 years, following SARS in 2002-2003 and MERS in 2012. While human strains of Coronavirus are associated with about 15% of cases of the common cold, the SARS-CoV-2 may present with varying degrees of severity, from flu-like symptoms to death. It is currently believed that this deadly Coronavirus strain originated from wild animals at the Huanan market in Wuhan, a city in Hubei province. Bats, snakes and pangolins have been cited as potential carriers based on the sequence homology of CoV isolated from these animals and the viral nucleic acids of the virus isolated from SARS-CoV-2 infected patients. Extreme quarantine measures, including sealing off large cities, closing borders and confining people to their homes, were instituted in January 2020 to prevent spread of the virus, but by that time much of the damage had been done, as human-human transmission became evident. While these quarantine measures are necessary and have prevented a historical disaster along the lines of the Spanish flu, earlier recognition and earlier implementation of quarantine measures may have been even more effective. Lessons learned from SARS resulted in faster determination of the nucleic acid sequence and a more robust quarantine strategy. However, it is clear that finding an effective antiviral and developing a vaccine are still significant challenges. The costs of the epidemic are not limited to medical aspects, as the virus has led to significant sociological, psychological and economic effects globally. Unfortunately, emergence of SARS-CoV-2 has led to numerous reports of Asians being subjected to racist behavior and hate crimes across the world.","J Autoimmun","Yang, Yongshi","Peng, Fujun","Wang, Runsheng","Guan, Kai","Jiang, Taijiao","Xu, Guogang","Sun, Jinlyu","Chang, Christopher","32143990"],"abstract":["The 2019-nCoV is officially called SARS-CoV-2 and the disease is named COVID-19. This viral epidemic in China has led to the deaths of over 1800 people, mostly elderly or those with an underlying chronic disease or immunosuppressed state. This is the third serious Coronavirus outbreak in less than 20 years, following SARS in 2002-2003 and MERS in 2012. While human strains of Coronavirus are associated with about 15% of cases of the common cold, the SARS-CoV-2 may present with varying degrees of severity, from flu-like symptoms to death. It is currently believed that this deadly Coronavirus strain originated from wild animals at the Huanan market in Wuhan, a city in Hubei province. Bats, snakes and pangolins have been cited as potential carriers based on the sequence homology of CoV isolated from these animals and the viral nucleic acids of the virus isolated from SARS-CoV-2 infected patients. Extreme quarantine measures, including sealing off large cities, closing borders and confining people to their homes, were instituted in January 2020 to prevent spread of the virus, but by that time much of the damage had been done, as human-human transmission became evident. While these quarantine measures are necessary and have prevented a historical disaster along the lines of the Spanish flu, earlier recognition and earlier implementation of quarantine measures may have been even more effective. Lessons learned from SARS resulted in faster determination of the nucleic acid sequence and a more robust quarantine strategy. However, it is clear that finding an effective antiviral and developing a vaccine are still significant challenges. The costs of the epidemic are not limited to medical aspects, as the virus has led to significant sociological, psychological and economic effects globally. Unfortunately, emergence of SARS-CoV-2 has led to numerous reports of Asians being subjected to racist behavior and hate crimes across the world."],"journal":"J Autoimmun","authors":["Yang, Yongshi","Peng, Fujun","Wang, Runsheng","Guan, Kai","Jiang, Taijiao","Xu, Guogang","Sun, Jinlyu","Chang, Christopher"],"date":"2020-03-08T11:00:00Z","year":2020,"_id":"32143990","week":"202010|Mar 02 - Mar 08","doi":"10.1016/j.jaut.2020.102434","keywords":["Bats","Coronavirus","Epidemic","Epidemiology","Flu","Human to human transmission","Pandemic","Pneumonia","Pyroptosis","SARS-CoV","SARS-CoV-2"],"source":"PubMed","locations":["Huanan","Asians","Hubei","Spanish","Wuhan","China"],"countries":["China","Spain"],"countries_codes":["CHN|China","ESP|Spain"],"topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1661359647762677761,"score":87.42087},{"pmid":32029004,"pmcid":"PMC7003341","title":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).","text":["A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).","In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province; and then named \"2019 novel coronavirus (2019-nCoV)\" by the World Health Organization (WHO) on 12 January 2020. For it is a never been experienced respiratory disease before and with infection ability widely and quickly, it attracted the world's attention but without treatment and control manual. For the request from frontline clinicians and public health professionals of 2019-nCoV infected pneumonia management, an evidence-based guideline urgently needs to be developed. Therefore, we drafted this guideline according to the rapid advice guidelines methodology and general rules of WHO guideline development; we also added the first-hand management data of Zhongnan Hospital of Wuhan University. This guideline includes the guideline methodology, epidemiological characteristics, disease screening and population prevention, diagnosis, treatment and control (including traditional Chinese Medicine), nosocomial infection prevention and control, and disease nursing of the 2019-nCoV. Moreover, we also provide a whole process of a successful treatment case of the severe 2019-nCoV infected pneumonia and experience and lessons of hospital rescue for 2019-nCoV infections. This rapid advice guideline is suitable for the first frontline doctors and nurses, managers of hospitals and healthcare sections, community residents, public health persons, relevant researchers, and all person who are interested in the 2019-nCoV.","Mil Med Res","Jin, Ying-Hui","Cai, Lin","Cheng, Zhen-Shun","Cheng, Hong","Deng, Tong","Fan, Yi-Pin","Fang, Cheng","Huang, Di","Huang, Lu-Qi","Huang, Qiao","Han, Yong","Hu, Bo","Hu, Fen","Li, Bing-Hui","Li, Yi-Rong","Liang, Ke","Lin, Li-Kai","Luo, Li-Sha","Ma, Jing","Ma, Lin-Lu","Peng, Zhi-Yong","Pan, Yun-Bao","Pan, Zhen-Yu","Ren, Xue-Qun","Sun, Hui-Min","Wang, Ying","Wang, Yun-Yun","Weng, Hong","Wei, Chao-Jie","Wu, Dong-Fang","Xia, Jian","Xiong, Yong","Xu, Hai-Bo","Yao, Xiao-Mei","Yuan, Yu-Feng","Ye, Tai-Sheng","Zhang, Xiao-Chun","Zhang, Ying-Wen","Zhang, Yin-Gao","Zhang, Hua-Min","Zhao, Yan","Zhao, Ming-Juan","Zi, Hao","Zeng, Xian-Tao","Wang, Yong-Yan","Wang, Xing-Huan","32029004"],"abstract":["In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province; and then named \"2019 novel coronavirus (2019-nCoV)\" by the World Health Organization (WHO) on 12 January 2020. For it is a never been experienced respiratory disease before and with infection ability widely and quickly, it attracted the world's attention but without treatment and control manual. For the request from frontline clinicians and public health professionals of 2019-nCoV infected pneumonia management, an evidence-based guideline urgently needs to be developed. Therefore, we drafted this guideline according to the rapid advice guidelines methodology and general rules of WHO guideline development; we also added the first-hand management data of Zhongnan Hospital of Wuhan University. This guideline includes the guideline methodology, epidemiological characteristics, disease screening and population prevention, diagnosis, treatment and control (including traditional Chinese Medicine), nosocomial infection prevention and control, and disease nursing of the 2019-nCoV. Moreover, we also provide a whole process of a successful treatment case of the severe 2019-nCoV infected pneumonia and experience and lessons of hospital rescue for 2019-nCoV infections. This rapid advice guideline is suitable for the first frontline doctors and nurses, managers of hospitals and healthcare sections, community residents, public health persons, relevant researchers, and all person who are interested in the 2019-nCoV."],"journal":"Mil Med Res","authors":["Jin, Ying-Hui","Cai, Lin","Cheng, Zhen-Shun","Cheng, Hong","Deng, Tong","Fan, Yi-Pin","Fang, Cheng","Huang, Di","Huang, Lu-Qi","Huang, Qiao","Han, Yong","Hu, Bo","Hu, Fen","Li, Bing-Hui","Li, Yi-Rong","Liang, Ke","Lin, Li-Kai","Luo, Li-Sha","Ma, Jing","Ma, Lin-Lu","Peng, Zhi-Yong","Pan, Yun-Bao","Pan, Zhen-Yu","Ren, Xue-Qun","Sun, Hui-Min","Wang, Ying","Wang, Yun-Yun","Weng, Hong","Wei, Chao-Jie","Wu, Dong-Fang","Xia, Jian","Xiong, Yong","Xu, Hai-Bo","Yao, Xiao-Mei","Yuan, Yu-Feng","Ye, Tai-Sheng","Zhang, Xiao-Chun","Zhang, Ying-Wen","Zhang, Yin-Gao","Zhang, Hua-Min","Zhao, Yan","Zhao, Ming-Juan","Zi, Hao","Zeng, Xian-Tao","Wang, Yong-Yan","Wang, Xing-Huan"],"date":"2020-02-08T11:00:00Z","year":2020,"_id":"32029004","week":"20206|Feb 03 - Feb 09","doi":"10.1186/s40779-020-0233-6","keywords":["2019 novel coronavirus","2019-nCoV","Clinical practice guideline","Evidence-based medicine","Infectious diseases","Pneumonia","Rapid advice guideline","Respiratory disease"],"source":"PubMed","locations":["Chinese","Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1661359647052791808,"score":86.36076},{"pmid":32127123,"title":"Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020.","text":["Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020.","A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countries, including Europe and Italy. Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases.","Euro Surveill","Bordi, Licia","Nicastri, Emanuele","Scorzolini, Laura","Di Caro, Antonino","Capobianchi, Maria Rosaria","Castilletti, Concetta","Lalle, Eleonora","On Behalf Of Inmi Covid-Study Group And Collaborating Centers","32127123"],"abstract":["A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countries, including Europe and Italy. Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases."],"journal":"Euro Surveill","authors":["Bordi, Licia","Nicastri, Emanuele","Scorzolini, Laura","Di Caro, Antonino","Capobianchi, Maria Rosaria","Castilletti, Concetta","Lalle, Eleonora","On Behalf Of Inmi Covid-Study Group And Collaborating Centers"],"date":"2020-03-05T11:00:00Z","year":2020,"_id":"32127123","week":"202010|Mar 02 - Mar 08","doi":"10.2807/1560-7917.ES.2020.25.8.2000170","keywords":["SARS-CoV-2","differential diagnosis","rapid molecular assay","respiratory pathogens"],"source":"PubMed","locations":["Italy","China"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1661359647666208769,"score":81.7907},{"pmid":32145185,"title":"Middle East respiratory syndrome.","text":["Middle East respiratory syndrome.","The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen that was first identified in humans in Saudi Arabia and Jordan in 2012. Intermittent sporadic cases, community clusters, and nosocomial outbreaks of MERS-CoV continue to occur. Between April 2012 and December 2019, 2499 laboratory-confirmed cases of MERS-CoV infection, including 858 deaths (34.3% mortality) were reported from 27 countries to WHO, the majority of which were reported by Saudi Arabia (2106 cases, 780 deaths). Large outbreaks of human-to-human transmission have occurred, the largest in Riyadh and Jeddah in 2014 and in South Korea in 2015. MERS-CoV remains a high-threat pathogen identified by WHO as a priority pathogen because it causes severe disease that has a high mortality rate, epidemic potential, and no medical countermeasures. This Seminar provides an update on the current knowledge and perspectives on MERS epidemiology, virology, mode of transmission, pathogenesis, diagnosis, clinical features, management, infection control, development of new therapeutics and vaccines, and highlights unanswered questions and priorities for research, improved management, and prevention.","Lancet","Memish, Ziad A","Perlman, Stanley","Van Kerkhove, Maria D","Zumla, Alimuddin","32145185"],"abstract":["The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen that was first identified in humans in Saudi Arabia and Jordan in 2012. Intermittent sporadic cases, community clusters, and nosocomial outbreaks of MERS-CoV continue to occur. Between April 2012 and December 2019, 2499 laboratory-confirmed cases of MERS-CoV infection, including 858 deaths (34.3% mortality) were reported from 27 countries to WHO, the majority of which were reported by Saudi Arabia (2106 cases, 780 deaths). Large outbreaks of human-to-human transmission have occurred, the largest in Riyadh and Jeddah in 2014 and in South Korea in 2015. MERS-CoV remains a high-threat pathogen identified by WHO as a priority pathogen because it causes severe disease that has a high mortality rate, epidemic potential, and no medical countermeasures. This Seminar provides an update on the current knowledge and perspectives on MERS epidemiology, virology, mode of transmission, pathogenesis, diagnosis, clinical features, management, infection control, development of new therapeutics and vaccines, and highlights unanswered questions and priorities for research, improved management, and prevention."],"journal":"Lancet","authors":["Memish, Ziad A","Perlman, Stanley","Van Kerkhove, Maria D","Zumla, Alimuddin"],"date":"2020-03-08T11:00:00Z","year":2020,"_id":"32145185","week":"202010|Mar 02 - Mar 08","doi":"10.1016/S0140-6736(19)33221-0","source":"PubMed","locations":["Riyadh","South Korea","Saudi Arabia","Jordan","Jeddah"],"countries":["Jordan","Korea, Republic of","Saudi Arabia"],"countries_codes":["JOR|Jordan","KOR|Korea, Republic of","SAU|Saudi Arabia"],"topics":["Transmission","Treatment","Diagnosis"],"weight":1,"_version_":1661359647772114945,"score":76.1735}]}